Coya Therapeutics, Inc. operates as a clinical-stage biotechnology company. The Company focuses on treatments for frontotemporal dementia, parkinson's and alzheimer's disease, sclerosis, and autoimmune conditions. Coya Therapeutics serves patients and healthcare professionals in the United States.